Structural Heart Closure Devices Market Capacity, Shares and Market Applications Forecast to 2022

The global structural heart closure devices market is expected to display positive growth in forthcoming years. Structural heart diseases include heart ailments that include functional and structural abnormalities of left and right ventricles, proximal vessels and heart valves. The reimbursement structure is likely to favor patients making procedures downright affordable and with aging, the Centers for Medicare and Medicaid Services continue supporting the procedures. These bodies indirectly help patients by listening to their redresses’ on the healthcare forum and easing the burden of healthcare expenditure to encourage people to opt for treatment.

Browse Details of Structural Heart Closure Devices Market Research Report at:

This is an encouraging factor for rendering assistance for Procedures such as Left Atrial Appendage closure (LAAC). LAAC reduces occurrence of strokes. Various investors are investing profound sums in R&D to remain mainstream and competitive and are waiting in the wings to obtain FDA approval in years ahead.

Segmentation of structural heart closure devices market includes Surgical Aortic Valve Replacement (SAVR), Trans catheter Aortic Valve Replacement (TAVR), Mitral Repair and Left atrial appendage closure (LAAC). By geography, segmentation includes North America, Europe, Asia Pacific, MEA. SAVR ruled in 2016 due to proven efficacy in treatments and strong reimbursement procedures.

LAAC is the fastest growing sectors in forthcoming years. Minimal invasive procedures for the heart are rapid promoters of growth in forecast period. The procedures reduce the risk of blood clotting and of stroke, that of ischemic stroke. North America is currently eyeing strong market growth in 2015 and minimally invasive procedures are the reason for this dominance.

Asia Pacific is projected to propel pace of growth in structural heart closure devices market growth and reasons include increasing awareness about cardiac diseases, better newborn screening programs to check congenital and other defects. Key news state that Johnson and Johnson expressed a desire to enter structural heart closure market with a leading stake in the market.

The key industry players in heart stoppage market include Boston Scientific, Medtronic, Edward Lifesynces Corporation, Abbott Laboratories and St Jude Medical, Biomerics, Comed BV and Cardiokinetix. A few companies such as Edward Life Sciences and Medtronic have welcomed clinical trials and have got Investigational Device Exception approval in August 2016. Japan Lifeline recommended the approval of figulla flex II manufactured by Occlutech. Occulutech works in the field of structural heart disease treatment.

Get Sample Copy of Structural Heart Closure Devices Market Research Report at:

Market Segment:

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• By Product
• Repair Devices
• Replacement Valves
• By Age Group
• Pediatric
• Adults

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
• Atrial Septal Defect (ASD)
• Ventricular Septal Defect (VSD)
• Patent Foramen Ovale (PFO)
• Aortic Valve Stenosis
• Others

See More Market Research Report Related to This Category at:

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Structural Heart Closure Devices in these regions, from 2012 to 2022 (forecast), covering
• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Structural Heart Closure Devices market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Boston Scientific Corporation
• Medtronic
• Edwards Lifesciences Corporation
• Abbott Laboratories
• Biomerics
• Comed BV
• LivaNova PLC
• JenaValve Technology, Inc.
• CardioKinetix

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Details:

Million Insights

Ryan Manuel

Office No. 302, 3rd Floor, Manikchand Galleria,

Model Colony, Shivaji Nagar, Pune, Maharashtra, 411016 India

Phone: 91-20-65300184


Visit Our Blog:

You May Also Like